A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
University of Massachusetts, Amherst
Pharmacyclics LLC.
SWOG Cancer Research Network
University of Chicago
BeOne Medicines
BeOne Medicines
Espad Pharmed
Hope Biosciences Research Foundation
Gilead Sciences
Acerta Pharma BV
Novartis
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
Novartis
Universität des Saarlandes
UNC Lineberger Comprehensive Cancer Center
Insel Gruppe AG, University Hospital Bern
Georgetown University
Celgene
Masonic Cancer Center, University of Minnesota
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Eisai Inc.
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
PrECOG, LLC.
Mayo Clinic
Celgene
Ohio State University Comprehensive Cancer Center
Hoffmann-La Roche
CarboFix Orthopedics Ltd.
Indivior Inc.
Incyte Corporation
Fred Hutchinson Cancer Center
Ipsen
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Mayo Clinic
AstraZeneca
BeiGene
Incyte Corporation
Stanford University
M.D. Anderson Cancer Center
Imperial College London
University of Rochester
VA Office of Research and Development
Nordic Nanovector
Novartis
City of Hope Medical Center